Paju A - Search Results

1

Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer: prognostic study on tissue and serum.

Paju A, Vartiainen J, Haglund C, Itkonen O, von Boguslawski K, Leminen A, Wahlström T, Stenman UH. Paju A, et al. Clin Cancer Res. 2004 Jul 15;10(14):4761-8. doi: 10.1158/1078-0432.CCR-0204-03. Clin Cancer Res. 2004. PMID: 15269150

2

Chorionic gonadotropin beta-subunit and core fragment in bladder cancer: mRNA and protein expression in urine, serum and tissue.

Hotakainen K, Haglund C, Paju A, Nordling S, Alfthan H, Rintala E, Stenman UH. Hotakainen K, et al. Among authors: paju a. Eur Urol. 2002 Jun;41(6):677-85. doi: 10.1016/s0302-2838(02)00125-2. Eur Urol. 2002. PMID: 12074787

3

Expression of the free beta-subunit of human chorionic gonadotropin in renal cell carcinoma: prognostic study on tissue and serum.

Hotakainen K, Ljungberg B, Haglund C, Nordling S, Paju A, Stenman UH. Hotakainen K, et al. Among authors: paju a. Int J Cancer. 2003 May 1;104(5):631-5. doi: 10.1002/ijc.11000. Int J Cancer. 2003. PMID: 12594819

4

Biochemistry and clinical role of trypsinogens and pancreatic secretory trypsin inhibitor.

Paju A, Stenman UH. Paju A, et al. Crit Rev Clin Lab Sci. 2006;43(2):103-42. doi: 10.1080/10408360500523852. Crit Rev Clin Lab Sci. 2006. PMID: 16517420 Review.

5

The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.

Paju A, Sorsa T, Tervahartiala T, Koivunen E, Haglund C, Leminen A, Wahlström T, Salo T, Stenman UH. Paju A, et al. Br J Cancer. 2001 May 18;84(10):1363-71. doi: 10.1054/bjoc.2001.1806. Br J Cancer. 2001. PMID: 11355948 Free PMC article.

6

Application of proteomic technology in identifying pancreatic secretory trypsin inhibitor variants in urine of patients with pancreatitis.

Valmu L, Paju A, Lempinen M, Kemppainen E, Stenman UH. Valmu L, et al. Among authors: paju a. Clin Chem. 2006 Jan;52(1):73-81. doi: 10.1373/clinchem.2005.056861. Epub 2005 Oct 27. Clin Chem. 2006. PMID: 16254194

7

Targeted gene-expression analysis by genome-controlled reverse transcription-PCR.

Stenman J, Paju A, Rissanen O, Tenkanen T, Haglund C, Räsänen J, Salo J, Stenman UH, Orpana A. Stenman J, et al. Among authors: paju a. Clin Chem. 2006 Nov;52(11):1988-96. doi: 10.1373/clinchem.2006.073064. Epub 2006 Sep 21. Clin Chem. 2006. PMID: 16990415

8

Expression of human chorionic gonadotropin beta-subunit type I genes predicts adverse outcome in renal cell carcinoma.

Hotakainen K, Lintula S, Ljungberg B, Finne P, Paju A, Stenman UH, Stenman J. Hotakainen K, et al. Among authors: paju a. J Mol Diagn. 2006 Nov;8(5):598-603. doi: 10.2353/jmoldx.2006.060076. J Mol Diagn. 2006. PMID: 17065429 Free PMC article.

9

Overexpression of human chorionic gonadotropin beta genes 3, 5 and 8 in tumor tissue and urinary cells of bladder cancer patients.

Hotakainen K, Lintula S, Jarvinen R, Paju A, Stenman J, Rintala E, Stenman UH. Hotakainen K, et al. Among authors: paju a. Tumour Biol. 2007;28(1):52-6. doi: 10.1159/000097703. Epub 2006 Dec 1. Tumour Biol. 2007. PMID: 17139196

10

Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells.

Paju A, Hotakainen K, Cao Y, Laurila T, Gadaleanu V, Hemminki A, Stenman UH, Bjartell A. Paju A, et al. Eur Urol. 2007 Dec;52(6):1670-9. doi: 10.1016/j.eururo.2007.01.096. Epub 2007 Feb 5. Eur Urol. 2007. PMID: 17306443

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters